BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 9633850)

  • 1. Management of borderline tumors of the ovary: state of the art.
    Tropé C; Kaern J
    Semin Oncol; 1998 Jun; 25(3):372-80. PubMed ID: 9633850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Borderline tumors of the ovary].
    Tropé CG; Baekelandt M; Bjørge T; Abeler V; Kaern J
    Tidsskr Nor Laegeforen; 2000 Sep; 120(23):2764-70. PubMed ID: 11107921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conservative surgery for borderline ovarian tumors: a review.
    Tinelli R; Tinelli A; Tinelli FG; Cicinelli E; Malvasi A
    Gynecol Oncol; 2006 Jan; 100(1):185-91. PubMed ID: 16216320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epithelial ovarian tumors in adolescence: a study of clinical features and treatment].
    Li M; Pan LY; Huang HF; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):598-601. PubMed ID: 15498186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical factors and biomarkers in ovarian tumors development.
    Vrabie CD; Petrescu A; Waller M; Dina I
    Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of epithelial ovarian tumors of low malignant potential.
    Trimble CL; Trimble EL
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S52-61. PubMed ID: 7835812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
    Veras E; Deavers MT; Silva EG; Malpica A
    Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical behavior of serous and mucinous borderline tumors of the ovary with diploid DNA stem line. Follow-up studies after organ preserving and non-organ preserving therapy].
    Mecke H; Börner-Klaussner B; Grosse G; Nadjari B; Hauptmann S
    Zentralbl Gynakol; 2000; 122(5):274-9. PubMed ID: 10857214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ovarian low malignant potential tumor: how to preserve fertility?].
    Koskas M; Madelenat P; Yazbeck C
    Gynecol Obstet Fertil; 2009; 37(11-12):942-50. PubMed ID: 19819742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conservative treatment of borderline ovarian tumors.
    Tazelaar HD; Bostwick DG; Ballon SC; Hendrickson MR; Kempson RL
    Obstet Gynecol; 1985 Sep; 66(3):417-22. PubMed ID: 4022501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Borderline ovarian tumors. Retrospective analysis of 20 cases].
    Iervolino P; Palmieri M; Rotondi M; D'Alessandro P; Iuliano R
    Minerva Ginecol; 2001 Feb; 53(1 Suppl 1):97-9. PubMed ID: 11526732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Borderline tumors of the ovary: a multicenter study in 137 patients].
    Bonnamy L; Fignon A; Fetissof F; Berger C; Body G; Lansac J
    J Gynecol Obstet Biol Reprod (Paris); 2001 May; 30(3):272-81. PubMed ID: 11398004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ovarian epithelial tumors of borderline malignancy].
    Katoh K; Izumi R
    Rinsho Byori; 1992 Feb; 40(2):119-31. PubMed ID: 1583784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.
    Sherman ME; Mink PJ; Curtis R; Cote TR; Brooks S; Hartge P; Devesa S
    Cancer; 2004 Mar; 100(5):1045-52. PubMed ID: 14983501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common epithelial tumors of borderline malignancy (carcinomas of low malignant potential).
    Scully RE
    Bull Cancer; 1982; 69(3):228-38. PubMed ID: 6289947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical staging, treatment, and follow-up of borderline tumors in different hospital categories: a prospective nationwide survey in Finland.
    Kumpulainen S; Kuoppala T; Leminen A; Komulainen M; Puistola U; Sankila R; Mäkinen J; Grénman S
    Acta Obstet Gynecol Scand; 2007; 86(5):610-4. PubMed ID: 17464592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
    McKenney JK; Balzer BL; Longacre TA
    Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.